curriculum vitae benzi michael kluger, m.d., m.s., f.a.a.n ... cv upd… · 2016 quoted expert on...
TRANSCRIPT
CURRICULUM VITAE
BENZI MICHAEL KLUGER, M.D., M.S., F.A.A.N.
Professor - Department of Neurology
12631 East Seventeenth Avenue- Mailstop B-185
Aurora, CO 80045
303.724.2194
303.724.2212 (Fax)
Education: University of Colorado – Boulder, Colorado
B.A. in Psychology,1997
University of Colorado School of Medicine – Aurora, Colorado
M.D., 2001
University of Florida – Gainesville, Florida
M.S. in Clinical Investigation, 2008
Internship, Internal Medicine – University of Colorado Denver
Aurora, CO
2001-2002
Residency, Neurology – University of Colorado Denver
Aurora, CO
2002-2005
Fellowship, Behavioral Neurology – University of Florida
Gainesville, FL
2005-2007
Fellowship, Movement Disorders – University of Florida
Gainesville, FL
2007-2008
Academic Appointments: Courtesy Assistant Professor – Department of Neurology, University of Florida
Gainesville, Florida
2007-2008
Assistant Professor – Departments of Neurology and Psychiatry, University of Colorado Denver
Aurora, CO
2008-2013
Faculty Associate – Departments of Neurosciences and Rehabilitation, University of Colorado Denver
Aurora, CO
2008-present
Chief – Movement Disorders Section, Department of Neurology, University of Colorado Denver
Aurora, CO
2008-2010
Director – Movement Disorders Center, University of Colorado Denver
Aurora, CO
2012-2016
Associate Professor – Departments of Neurology and Psychiatry, University of Colorado Denver
Aurora, CO
2013-present
Chief and Founder – Neurology Supportive and Palliative Care Section, Department of Neurology,
University of Colorado Denver
Aurora, CO
2016-present
Professor – Departments of Neurology and Psychiatry, University of Colorado Denver
Aurora, CO
2018-present
Honors, Special Recognitions, and Awards: 1994 CU Alumni Association Scholarship
1994-1997 Dean’s List
1996, 1997 Dean’s Scholarship
1997 Member Phi Beta Kappa
1998 Best Nutrition Abstract, Western Medical Student Research Forum
1998 C. Everett Koop Award, American Society for Clinical Nutrition
1999, 2000 Colorado Representative to Western Medical Student Research
2001 Voted “Most Liked to be on Cover of Time” by Graduating Class
2003 Outstanding Clinical Teacher, University of Colorado School of Medicine
2004 American Academy of Neurology, Annual Meeting Scholarship
2005 American Neuropsychiatric Association’s, Young Investigator Award
2005 Travel Award to EEG and Clinical Neuroscience Society Meeting, Munich, Germany
2006 American Academy of Neurology, Foundation Corporate Roundtable Clinical Research
Fellowship
2006 Advanced Post-Graduate Program in Clinical Investigation Fellow (NIH K-30 Program)
2007 Scholarship to University of California at Davis Center for Mind and Brain Course in
Event Related Potentials (NIH Sponsored Course). Director: Steve Luck
2007 Travel Award to Florida Society of Neurology’s Residents and Fellows Research Day
2010 Colorado Clinical and Translational Sciences Institute, Clinical Faculty Scholar
2010 National Institutes of Neurological Disease and Stroke, Clinical Trials Course
Scholarship
2011 University of Colorado Denver, Chancellor’s Diversity Recognition Award for Faculty
Leadership
2012 American Academy of Neurology, Leadership Development Scholarship
2012 American Academy of Neurology, Poster Recognized in “Imaging Highlights”
Presentation and Behavioral Neurology Poster Tour
2012 Featured Neurologist in Denver Post’s Daily Dose, “Parkinson Study In Colorado Uses
Acupuncture for Fatigue, More Subjects Needed
2012 Featured Neurologist on Channel 9 News Parkinson Call Line, Denver
2012 Quoted expert on fatigue in Parkinson’s disease, Neurology Now; 8(6): 22-27. Valeo T.
Not just tremor: recognizing depression and other non-motor symptoms of Parkinson’s
disease.
2012 Featured in article Duran, B. Acupuncture Study Brings Hope for Parkinson's Disease
Patients. Acupuncture Today. 2012; 13(2).
2013 Quoted expert on transcranial magnetic stimulation. Neurology Today; 13(18):32-7.
Talan J. A new tool for determining levels of consciousness.
2014 Article “Palliative Care and Neurology: Time for a Paradigm Shift” featured on
American Academy of Neurology’s podcast and Media Watch (Issue 366, July 14, 2014)
2015 Featured expert in Neurology Today 15(8):22-23: Shaw G. Is palliative care in neurology
lagging behind, or on the cusp of something big?
2016 Invited Expert for Patient Centered Outcomes Research Institute (PCORI) Stakeholder
Workshop “Prioritizing comparative effectiveness research questions for patient-centered
care delivery for adult patients with advanced illness and their caregivers”
2016 Article “Randomized controlled trial of acupuncture for fatigue in Parkinson’s disease”
featured in Neurology Advisor, Psychiatry Advisor and Journal of Chinese Medicine.
2016 Quoted expert on palliative care and end-of-life communication. Neurology Today;
16(9):26-28. Shaw G. Communication about End-of-Life Preferences Still Lacking,
Stroke Study Finds.
2016 Elected as Fellow Member of the American Academy of Neurology.
2016 Abstracts “Does outpatient palliative care improve patient centered outcomes in
Parkinson’s disease: study protocol for a multi-centered randomized controlled trial” and
“Differences between actual and perceived treatment groups in a double-blind placebo
trial of acupuncture for fatigue in Parkinson’s disease” were recognized as leading
abstracts and selected to be part of poster tours at 2016 World Parkinson Congress.
2017 Accepted for the 2017 American Academy of Neurology Palatucci Advocacy Leadership
Forum.
2017 Highlighted as “Featured Doctor - May 2017” on University of Colorado Medicine
website.
2017 Featured in Momentum, an annual publication that celebrates the power and impact of
philanthropy at the University of Colorado Anschutz Medical Campus.
2018 Selected for participation in the American Academy of Neurology’s Transforming
Leadership Program.
2018 Quoted expert on palliative care in movement disorders in Palliative Care in Movement
Disorders: Recommendations for Improvement
2018 Invited participant in Palliative Care Consensus Conference, Newark NJ, November 8-9,
2018.
Professional Organizations and Affiliations: 2002-present American Academy of Neurology
2005-present American Neuropsychiatric Association
2006-present Society for Behavioral and Cognitive Neurology
2008-present Movement Disorders Society
2009-present Parkinson Study Group
2009-present Parkinson Disease Society
2010-present Huntington’s Study Group
2013-present American Neurological Association
Major Committee and Service Responsibilities:
University of Colorado School of Medicine:
2008-present Department of Neurology – Faculty Advisor, Behavioral Neurology and Neuropsychiatry
Fellowship
2008-present Department of Neurology - Director, Transcranial Magnetic Stimulation Laboratory
2009-2010 Department of Neurology - Chief, Movement Disorders Section
2009-2010 Department of Neurology – Director, Movement Disorder’s Fellowship
2011-present Department Spine and Rehabilitation – Faculty Associate for the Graduate Sciences
Program
2012-2016 Department of Neurology – Director and Founder, Movement Disorders Center
2012-present Department of Neurology – Faculty Associate for Graduate Program
2012-2016 Department of Neurology – Director and Founder, Movement Disorders Center
2013-present Director, Magnetoencephalography Laboratory
2013-present Chair and/or member, Doctoral Committees for Individual Rehabilitation Sciences
Program Applicants (Ryan Marker, Jean Berliner)
2015-present Chair, Doctoral Committee for Neuroscience Graduate Program Applicants (Jason
Smucny)
2015-present Department of Neurology – Internal Promotions Review Committee
2016-present Department of Neurology – Internal Pilot Grant and Mini-sabbatical creation and review
committee
2016-present Member, Doctoral Committees for Individual Biomedical Engineering Program
Applicants (Michael Regner)
2016-present Founder and Chief, Palliative Care Section, Department of Neurology
Hospital: 2008-present Clinical Advisor, Thriving after Cancer Treatment Is Complete (TACTIC) Program,
University of Colorado Hospital Children’s Hospital Colorado
2009-2010 Program Director, Movement Disorders Program, University of Colorado Hospital
2013-present Director and Founder, Supportive and Palliative Care Clinic for Neurologic Illness
2013-present Director, Clinical Magnetoencephalography Program
2015-2016 Director and Founder, Interdisciplinary Clinic for Parkinson’s disease
2015-2016 Director and Founder, Group Clinic for Newly Diagnosed Parkinson’s disease
Community:
2010-2016 Parkinson Association of the Rockies - Program Committee Member
2012 Regional Continuing Medical Education (CME) Event Director and Speaker: Parkinson’s
Disease and Multiple Sclerosis Update. Englewood, CO.
2013 Regional Continuing Medical Education (CME) Event Director and Speaker: Non-
Parkinson’s Movement Disorders and Epilepsy Update. Englewood, CO.
National:
2013-present Member, Clinical Research Subcommittee – American Academy of Neurology
2015-present Member, Pain and Palliative Care Subcommittee – American Academy of Neurology
2018 Delegate for Neurology on the Hill – American Academy of Neurology
International:
2011-present Editorial Board – Frontiers in Movement Disorders
2014 Invited Presenter/Member – World Parkinson Congress/Parkinson Disease Foundations
Sponsored Working Group on Fatigue in Parkinson’s disease
2015 Director of First Parkinson Foundation Funded International Working Group on
Palliative Care and Parkinson’s Disease
2016 Co-Director of Parkinson Foundation Funded International Working Group on Palliative
Care and Parkinson’s Disease
2017 Co-Director of International Neuropalliative Care Summit Working Group Meeting
2017 Founding Member of Research Advisory Council of the Academy of Neurologic Music
Therapy
2017 Editorial Board – Nature Publishing Journals (NPJ) Parkinson Disease
2018 Co-Director – Education in Palliative and End-of-life Care (EPEC) Neurology
Adaptation
Licensure and Board Certification: 2005-2008 State of Florida
2006-present American Board of Psychiatry and Neurology, Certificate #53650
2008-present State of Colorado
2016-present State of Wyoming
Review and Referee Work:
Journals
Editorial Board, Frontiers in Movement Disorders
Editorial Board, NPJ Parkinson Disease (Nature Publishing Journal)
Ad Hoc Reviewer, American Journal of Geriatric Pharmacotherapy
Ad Hoc Reviewer, BMC Palliative Care
Ad Hoc Reviewer, BMJ Open
Ad Hoc Reviewer, Brain, Behavior, and Immunity
Ad Hoc Reviewer, Brain Injury
Ad Hoc Reviewer, Brain Topography
Ad Hoc Reviewer, Clinical Neurophysiology
Ad Hoc Reviewer, Journal of Clinical and Experimental Neuropsychology
Ad Hoc Reviewer, Journal of Neural Transmission
Ad Hoc Reviewer, Journal of the International Neuropsychological Society
Ad Hoc Reviewer, Journal of the Neurological Sciences
Ad Hoc Reviewer, Journal of Neuropsychiatry and Clinical Neurosciences
Ad Hoc Reviewer, Movement Disorders
Ad Hoc Reviewer, Neurodegnerative Disease Management
Ad Hoc Reviewer, Neurology
Ad Hoc Reviewer, Neuropsychologia
Ad Hoc Reviewer, Open Journal of Parkinsons Disease and Treatment
Ad Hoc Reviewer, Parkinsonism and Related Disorders
Ad Hoc Reviewer, PLOS ONE
Ad Hoc Reviewer, Scientific Reports Nature Publishing Group
Ad Hoc Reviewer, Journal of Geriatric Psychiatry and Neurology
Ad Hoc Reviewer, Journal of Parkinson’s Disease
Ad Hoc Reviewer, Brain Imaging and Behavior
Ad Hoc Reviewer, OBM Integrative and Complementary Medicine
Ad Hoc Reviewer, JAMA Neurology
Editorial Board, Annals of Palliative Medicine
Grant Reviews
Ad Hoc Grant Reviewer, Canada Research Chairs Program, Canada
Ad Hoc Grant Reviewer, Marsden Fund, New Zealand
Ad Hoc Grant Reviewer, Multiple Sclerosis Society, United Kingdom
Ad Hoc Grant Reviewer, National Institutes of Neurological Disease and Stroke
Ad Hoc Grant Reviewer, National Science Foundation
Ad Hoc Grant Reviewer, Parkinson Disease Society, United Kingdom
Ad Hoc Grant Reviewer, Michael J Fox Foundation
Ad Hoc Grant Reviewer, Lister Prize Fellowship
Invited Lectures and Presentations: Local:
Kluger B. The Neurology of Free Will. Neurology Grand Rounds, UCD. April 2005.
Kluger B. Non-Motor Symptoms of Parkinson Disease. Invited Speaker. Parkinson Partner
Support Group, Denver, CO. March 2009.
Kluger B. Transcranial Magnetic Stimulation. Invited Speaker. University of Colorado Brain
Imaging Center, Aurora, CO. May 2009.
Kluger B. Management of Non-motor Symptoms. Invited Speaker. Parkinson Association of the
Rockies Patient Education Seminar, Denver, CO. February 2010.
Kluger B. Neurologic Applications of Transcranial Magnetic Stimulation. Neurology Grand
Rounds, UCD. September 2010.
Kluger B. Memory Loss and Enhancement, Myths and Reality. Invited Speaker. Osher Lifelong
Learning Institute Speakers Series, Leading Edge Medicine, The Latest in Research and
Treatment, Denver, CO. January 2011.
Kluger B. Enhancing Creativity. Invited Speaker. Clinical Faculty Scholars Program Special
Topics Seminar, UCD. July 2011.
Kluger B. Fatigue in Neurological Disorders. Neurology Grand Rounds, UCD. November 2011.
Kluger B. Non-Motor Symptoms of Parkinson’s and Parkinson Disease Overview. Parkinson
Association of the Rockies, Loveland, CO. November 2011.
Kluger B. Discussion of Cutting-Edge Research and the Role that Patients Play. Invited Speaker.
Parkinson Clinical Research in Colorado, Denver, CO. May 2012.
Kluger B. Cognition in Parkinson Disease. Invited Speaker. University of Colorado Denver
NeuroScience Program Membership Seminar, Denver, CO. June 2012.
Kluger B. Research Roundtable Event, Invited Speaker. Parkinson Association of the Rockies,
Denver, CO. December 2012.
Kluger B. Common Health Issues in Parkinson’s Disease. Invited Speaker. Parkinson’s
Association of the Rockies, Colorado Springs, CO. February 2013.
Kluger B. The PD You Don’t See: Cognitive and Non-motor Symptoms. Invited Speaker. 2013
Parkinson’s Symposium, Colorado Springs, CO. May 2013.
Kluger B. Palliative Care in Neurology: Time for a Paradigm Shift. Neurology Grand Rounds,
UCD. September 2013.
Kluger B. Palliative Care and Neurology. Palliative Care Grand Rounds, UCD. December 2013.
Kluger B (and others in Movement Disorders Division). Movement Disorders Phenomenology
via YouTube. Neurology Grand Rounds, UCD. February 2013.
Kluger B. Movement Disorders Center Symposium “To the Future and Back.” Director and
Speaker. Aurora, CO. September 2014.
Kluger B. Movement Disorders in an Aging Population: Are we making progress? Invited
Speaker. Osher Lifelong Learning Institute Speakers Series, Leading Edge Medicine, Denver,
CO. February 2015.
Kluger B. 2nd Annual Movement Disorders Center Symposium. Director and Speaker. Aurora,
CO. September 2015.
Kluger B. Palliative Care and Parkinson’s disease: Needs, Gaps and Recommendations.
Neurology Grand Rounds, UCD. December, 2015.
Kluger B. 3rd Annual Movement Disorders Center Symposium. Director and Speaker. Aurora,
CO. October 2016.
Kluger B. Novel Models for the Care of Older Adults Affected by Neurodegnerative Illnesses.
Geriatrics Grand Rounds, UCD. November, 2016.
Kluger B. Neuro-palliative Care Clinical and Research Program. Invited Speaker. Palliative Care
Days, UCD. November 2016.
Kluger B. Physician Assisted Death in Neurology: Clinical, Ethical and Legal Aspects.
Neurology Grand Rounds, UCD. July 2017.
Kluger B. Palliative Care. Palliative Care for Anesthesiologists. Anesthesia Grand Rounds, UCD,
October, July 2017.
Kluger B. Medicine as a Spiritual Practice. Invited Speaker. Palliative Care Days, UCD. October
2016.
Kluger B. Sleep and Fatigue. 4th Annual Movement Disorders Center Symposium. Director and
Speaker. Aurora, CO. September 2017.
Regional:
Kluger B. Non-Motor Symptoms of Parkinson’s and Parkinson Disease Overview. Invited
Speaker. Parkinson Association of the Rockies, Casper, WY. October 2011.
Kluger B. Parkinson’s Disease Patient Roundtable. University of Colorado Neurology Regional
Continuing Medical Education Event. September 2012.
Kluger B. Colorado Parkinson's Research Update. Invited Speaker. Davis Phinney Victory
Summit, Denver, CO. November 2012.
Kluger B. Palliative Care and Neurology. University of Colorado Regional Continuing Medical
Education Event, Englewood, CO. September 2013.
Kluger B. Three talks: Psychological Issues and Management; Sleep and Fatigue; Questions you
have always been afraid to ask. Global Community Conference on Parkinson’s Disease,
Keystone, CO. March 2014.
Kluger B. Panelist, Research: The Road Ahead. Partner’s in Parkinson’s Conference. Denver,
CO. November 2014.
Kluger B. Magnetoencephalography. Invited Speaker. University of Colorado Regional
Continuing Medical Education Event, Englewood, CO. October 2014.
Kluger B. Neuroimaging and Neurostimulation: Going inside the Black Box. Invited Speaker.
Colorado Community Conference (on Parkinson’s), Denver, CO. April 2015.
Kluger B. Palliative Care and Multiple Sclerosis. Invited Speaker. Rocky Mountain Multiple
Sclerosis Center Education Summit. Golden, CO. October 2015.
Kluger B. Quality of Life Care and End of Life. Invited Speaker. Alzheimer’s Association of
Colorado Annual Education Symposium. Denver, CO. November 2015.
Kluger B. Complementary Therapies. Invited Speaker. Davis Phinney Foundation Victory
Summit. Durango, CO. July 2017.
Kluger B. Research Update on Multiple Systems Atrophy. Invited Speaker. Colorado
Neurological Institute. August 2017.
Kluger B. Educate Session: Marijuana Research. Invited Speaker. E3 Conference - Educate,
Empower, Energize. Parkinson Association of the Rockies. September 2017.
Kluger B. Medicine as Spiritual Practice. Invited Speaker. 12th Annual Current Perspectives on
Palliative Care: Across the Care Continuum. October 2017.
Kluger B. What’s New in Palliative Care? What Can it Offer Neurology? Invited Speaker.
Academy of Lifelong Learning. November 2017.
Kluger B. The Colorado End of Life Options Act: Opportunities, Challenges and Responsibilities
for Neurologists. Invited Speaker. Colorado Society of Clinical Neurologists. January 2018.
Kluger B. Comprehensive care for end-stage neurodegenerative disease. 16th annual Rocky
Mountain Geriatrics Conference. Broomfield, CO. September 2018.
National:
Kluger B. Zinc homeostasis in infants with cystic fibrosis. Abstract Presentation. Western
Medical Student Research Forum, Carmel, CA. February 1998.
Kluger B. Volitional Action as Assessed by Magnetoencephlography. Poster Presentation.
American Neuropsychiatric Association Annual Meeting, Bal Harbour, FL. February 2005.
Kluger B. The Neurology of Free Will. Invited Speaker. Center for Neuropsychological Studies
Symposium, Gainesville, FL. October 2005.
Kluger B. Aging and Fatigue. Invited Speaker. Florida Society for Neurology’s 32nd Annual
Course in Neuropsychology and Behavioral Neurology, Orlando, FL. December 2006.
Kluger B. The Neuropsychology of Fatigue. Invited Speaker. 5th Gator Pre-International Society
for Neuropsychology Neuroscience Meeting, Mount Hood, OR. February 2007.
Kluger B. Dysfunctional Facial Emotional Expression and Comprehension in a Patient with
Corticobasal Degeneration. Poster Presentation. International Society for Neuropsychology
Annual Meeting, Portland, OR. February 2007.
Kluger B. Somatosensory Evoked Potentials and the Timing of Perception. Poster Presentation.
College of Medicine Research Day, Gainesville, FL. March 2007.
Kluger B. A Test of the Mechanisms of Sensory Extinction to Simultaneous Stimulation. Poster
Presentation. American Academy of Neurology Annual Meeting, Boston, MA. May 2007.
Kluger B. An fMRI Study of the Crossed Response Inhibition Test in Parkinson Disease. Poster
Presentation. Cognitive Neuroscience Society Annual Meeting, Manhattan, NY. May 2007.
Kluger B. Neuropsychological Correlates of Fatigue in Parkinson Disease. Poster Presentation.
Advances in Neurology and the 2nd Florida Neurology Residents and Fellows Research Day,
Orlando, FL. September 2007.
Kluger B. Fatigue in Aging and Dementia. Invited Speaker. Florida Society for Neurology’s 33rd
Annual Course in Neuropsychology and Behavioral Neurology, Gainesville, FL. December 2007.
Kluger B. Objective Cognitive Fatigue in Parkinson Disease. Invited Speaker. Center for
Neuropsychological Studies Symposium, Gainesville, FL. April 2008.
Kluger B. The Prevalence and Clinical Significance of Fatigue Following Deep Brain
Stimulation in Parkinson Disease. Poster Presentation. American Academy of Neurology Annual
Meeting, Chicago, IL. April 2008.
Kluger B. Non-Motor Symptoms of Dystonia. Invited Speaker. Tyler’s Hope Dystonia Think
Tank, Gainesville, FL. March 2009.
Kluger B. Parkinson Disease Update. Invited Speaker. Avera McKennan Hospital and University
Health Center Neurosciences Grand Rounds, Sioux Falls, SD. October 2009.
Kluger, B. Bioethics and Parkinson Disease. Invited Speaker. Parkinson Advocates in Research
Learning Institute, Industry City, CA. July 2012.
Kluger B. Non-Motor Symptoms in Parkinson Disease. Invited Speaker. Creighton University
Parkinson Symposium, North Platte, NE. May 2010.
Kluger B. Fatigue and Sleep Complaints in Dystonia. Invited Speaker. 5th Annual Think Tank on
Novel Approaches to a cure for DYT-1 Dystonia, Gainesville, FL. March 2012.
Kluger B. The PD You Don’t See: Cognitive and Non-motor Symptoms. Invited Speaker. Davis
Phinney Foundation Victory Summit, Phoenix, AZ. January 2013.
Kluger B. Ataxia Poster Session Highlights. Invited Moderator. American Academy of
Neurology Annual Meeting, San Diego, CA. March, 2013.
Kluger B. Parkinson’s disease is more than just a movement disorder: Cognitive and other
Nonmotor symptoms. Invited Speaker. Parkinson’s Disease Southern Symposium, Spartanburg,
SC. November, 2014.
Kluger B. Two Lectures: “The PD you don’t see: Cognitive and other non-motor symptoms” and
“Medication Management”. Invited Speaker. Davis Phinney Victory Summit, Greenville, SC,
November, 2014.
Kluger B. Parkinson’s research priorities and what’s in the research pipeline. Invited Speaker.
Parkinson Disease Foundation Parkinson Advocates in Research Learning Institute, Florham
Park, NJ, March, 2015.
Kluger B. Palliative Care and Neurology: Time for a Paradigm Shift. Invited Speaker. Florida
Blue Center for Health Care Quality Distinguished Scholars Lecture. University of Florida
School of Nursing, Gainesville, FL, September 2014.
Kluger B. Two lectures: “The PD You Don’t See: Cognitive and Non-motor Symptoms” and
“Alternative Options: Complimentary Therapies”. Invited Speaker. Davis Phinney Victory
Summit, San Antonio, TX, November 2015.
Kluger B. Palliative Care, Non-motor Symptoms and Patient Engagement. Invited Speaker.
Parkinson Disease Foundation Self-Efficacy Leadership Course. Denver, CO, May, 2016.
Kluger B. What’s new in palliative care? What can it offer neurology? Invited Speaker. Rush
Movement Disorders Center Seminar. Chicago, IL. June 2016.
Kluger B. Making a Difference in the Research Process. Invited Speaker and Patient Engagement
Session Invited Panelist. Parkinson Disease Foundation Parkinson Advocates in Research
Learning Institute, Florham Park, NJ, July, 2016.
Kluger B. What’s new in palliative care? What can it offer neurology? Invited Speaker.
University of Florida Neurology Grand Rounds. Gainesville, FL. July 2016.
Kluger B. Alternative Options: Complimentary Therapies. Invited Speaker. Davis Phinney
Victory Summit, Sacramento, CA, October 2016.
Kluger B. Two lectures: “The PD You Don’t See: Cognitive and Non-motor Symptoms” and
“Alternative Options: Complimentary Therapies”. Invited Speaker. Davis Phinney Victory
Summit, New Orleans, LA, November 2016.
Kluger B. Futures in Clinical Research Luncheon. Invited Panelist. Boston, MA, April 2017.
Kluger B. “PCORI. What’s all the fuss?” Invited Speaker. 69th American Academy of
Neurology Annual Meeting, Boston, MA, April 2017.
Kluger B. “Making the Transition from Research Fellow to Clinical Research Faculty.” Invited
Small Group Facilitator. 69th American Academy of Neurology Annual Meeting, Boston, MA,
April 2017.
Kluger B. Sleep/Non-Motor Symptoms; Cannabis. Invited Speaker. Parkinson’s Wellness
Recovery Retreat, Scottsdale AZ, May 2017.
Kluger B. Research Transformation: The Power of Engagement. Invited Speaker and Discussant.
Academy Health Annual Research Meeting, New Orleans, LA, June 2017.
Kluger B. Not Just the Shakes: Non-motor Symptoms; Exploring Complementary Therapies.
Invited Speaker, David Phinney Foundation Victory Summit, Lubbock TX, February 2018.
Kluger B. Marijuana and PD, What do we really know? Invited Speaker. Parkinson Foundation's
Expert Briefings on April 17, 2018.
Kluger B. Improving Care and Outcomes for Patients with Advanced Illnesses and their
Caregivers. Invited Speaker. PCORI Annual Meeting, Washington DC, November 1, 2018.
Kluger B. Palliative Care and Parkinson’s: Moving from Comparative Effectiveness to
Implementation. University of Rochester, Grand Rounds, Rochester NY, November 2, 2018.
Kluger B. NeuroPalliative Care: Unique Challenges and Opportunities in an Emerging
Subspecialty. University of Rochester, Palliative Care Symposium, Rochester NY, November 2,
2018.
Kluger B. The PD You Don’t See: Cognitive and Non-motor Symptoms. Parkinson Voice
Project, Parkinson’s Lecture Series, Richardson TX, November 10, 2018.
International:
Kluger B. Volitional Action as Assessed by Magnetoencephalography. Poster Presentation. EEG
and Clinical Neuroscience and International Society for Neuroimaging in Psychiatry Joint
Conference, Munich, Germany. September 2005.
Kluger B. The role of people with Parkinson’s in the research process: how are they prepared and
what can they do? Panelist. World Parkinson Congress, Montreal, Canada. October 2013.
Kluger B. Palliative Care and Parkinson’s Disease International Working Group. Conference
Director and Speaker. Aurora, CO, October, 2015.
Kluger B. The PD you don’t see: Cognitive and other non-motor symptoms. Invited Speaker.
Davis Phinney Victory Summit, Ipoh, Malaysia, October, 2015.
Kluger B. Palliative Care and Parkinson’s Disease Second International Working Group.
Conference Co-Director and Speaker. Portland, OR, September, 2016.
Kluger B. Three talks: 1) Cannabis and Parkinson’s: What’s all the fuss? (Roundtable Host); 2)
What is palliative care and why is it relevant to PD?; and 3) Research on Cannabis: is there any
evidence?. Invited Speaker. World Parkinson Congress, Portland, OR. September 2016.
Kluger B. Neuro-Palliative Care Summit Meeting. Discussant and Co-director. Boston, MA,
April 2017.
Kluger B. Apathy and Non-Motor Symptoms. Invited Speaker. Parkinson Society British
Columbia Provincial Conference, Vancouver, BC. June 2017.
Kluger B. Complementary Care. Invited Speaker. Parkinson Society British Columbia Provincial
Conference, Vancouver, BC. June 2017.
Kluger B. Incorporating Complementary Medicine into Movement Disorders Care. Invited
Speaker. 21st International Congress of Parkinson’s Disease and Movement Disorders. June 2017.
Kluger B. Exploring Options: Complementary Therapies. Invited Speaker. Davis Phinney
Victory Summit, Toronto, Canada, October, 2017.
Kluger B. Marijuana and PD, What do we really know? Invited Speaker. Parkinson Insight 2018
Summit, Australia, April, 2018.
Kluger B. Complementary and Alternative Medicine in Parkinson’s Disease. Invited Speaker and
Session Chair. 22nd International Congress of Parkinson’s Disease and Movement Disorders,
Hong Kong, October 2018.
Kluger B. Palliative Care in Parkinson’s Disease and Related Disorders; Palliative Care in
Dementia; Advance Care Planning for Neurology Patients. Invited Speaker. FINE-MAHE
Weekend Course on Palliative Care in Neurology. Manipal, India, January 2019.
Kluger B. Palliative Care in Life-limiting Neurologic Illnesses. Invited Speaker. Indian
Association of Palliative Care Annual Conference. Kochi, India, January 2019.
Teaching Record: Presentations to Faculty and Staff:
2015 Pain in Multiple Sclerosis. Multiple Sclerosis Section Lecture.
2017 Palliative Care in Neurology. Physical, Occupational and Speech Therapists Inservice,
UCH.
2017 Palliative Care. Neurology Clinic Staff Inservice, UCH.
Presentations to Medical Students:
2005-2008 BMS 6811: Clinical Diagnosis. Single Lecture: “Delirium and Dementia,” University of
Florida
2007-2008 BMS 6020: Medical Neuroscience. Single Lecture: “Behavioral and Cognitive
Neurology,” University of Florida
2008-present Foundations of Doctoring Course: The Neurological Exam. University of Colorado
Denver
2009-present MED 8029: Applied Clinical Pharmacology. Single Lecture: “Pharmacologic Treatment
of Parkinson Disease,” University of Colorado Denver
2014 MRSC 7614: Biological Basis of Psychiatric and Neurological Disorders. Single Lecture:
“Dementia with Lewy Bodies,” University of Colorado Denver
Presentations to Graduate Students
2017 Director of PALC 6310, week-long Neurology Module for Master’s in Palliative Care
Program
Presentations to House Officers and Fellows:
2008-present Neurology Resident Education Seminars. 3-6 Lectures per Year Including: “Movement
Disorder Emergencies,” “Medical Management of Movement Disorders,” “Atypical
Parkinsonian Disorders,” “Behavioral Neurology Overview,” and “Palliative Care for
Behavioral Neurology,” University of Colorado Denver
2008-present Movement Disorders Fellowship Seminars: Seminar, including both Journal Club and
Didactic presentations.
2009-present Neurology Journal Club, Various palliative care, movement disorders, behavioral
neurology and neurophysiology articles. University of Colorado Denver
2011-present Physical Medicine and Rehabilitation Residency Seminars. Single Lecture: “Dementia,”
University of Colorado Denver
2013-present Psychiatry Residency Seminar: “Movement Disorders for Psychiatrists”, University of
Colorado Denver
2014- Palliative Care Fellowship Seminars: “Movement Disorders” and “Dementia” lectures
Ward/Clinic Attending Duties:
2008-present Supervision and teaching of neurology residents and medical students on general
neurology/stroke service at University of Colorado Hospital and/or Denver Health
Medical Center. One to four weeks per year.
2008-present Supervision and teaching of movement disorders fellow, neurology residents and medical
students in Movement Disorders clinic.
2016-Present Supervision and teaching of movement disorders fellow, behavioral neurology fellow,
palliative care fellow, geriatrics fellow, neurology residents, internal medicine residents
and medical students in Neurology Palliative Care Clinic.
Other Specific Accomplishments:
Neurology Department:
2004-2005 Residency Education Director
2008-present Faculty resident mentor – Drs. Eryn Lonnquist, Jason Fleming, Louis DiSalvo
2009-2010 Movement Disorders Fellowship Director
2009-present Faculty fellow research mentor – Drs. Daniel Kuyper, Aaron Haug, Jessica Hedeman,
Taylor Finseth, Samantha Holden, Brice McConnell
2010-2013 Faculty Mentor, Psychiatry Scholars Program (Keith Baker)
2011-present Faculty mentor, School of Medicine Mentored Scholarly Activity (Matthew Von Loh,
Jeffery Ferrier, Wallace Jones, William Silkworth, Nathaniel Dusto, Derek George, Ivan
Trang)
2012 Faculty judge, Neurology resident research presentations
2012 Faculty Mentor, Psychiatry Residency Program – Dr. Mycroft Smith
2012-present Junior Faculty Mentor (Samantha Holden, Brice McConnell, Hilary Lum, Brett
McQueen, Christina Vaughan)
2018 Developer and speaker, Neuropalliative Care Neurology Residency Lecture Block
University of Colorado Anschutz Medical Campus:
2008-2012 Faculty mentor, LABCOATS program (Initiative for Maximizing Student Diversity
NIGMS-IMSD R25GM08333; Veronica Parra, Shanae Aerts, Zachary Baud)
2009-present Faculty research mentor, University of Colorado Denver Undergraduate Internship
(Sheena Shipley, Katherine Heese, Toni Qualatone, Benjamin Mountjoy, Renee
Andrews, Piera Triolo)
2010-present Rehabilitation Science Graduate Program Mentor (Jennifer Stephenson, Abbey Thomas,
Ryan Marker)
2012-present Regis University Neurosciences Undergraduate Internship (Matthew Binder, Kelly
Sebring)
2012-2013 Faculty research mentor, University of Colorado School of Public Health Practicum
(Kristina Johnson)
2013-present Faculty Research Mentor, University of Colorado Denver Undergraduate Pre-health
Program (Jamal Zahir)
2013-present Foundations of Doctoring Mentor, University of Colorado School of Medicine (Ann
Scheel, Claire Koljack)
Grant Support:
University of Colorado Denver (UCD), Cancer Center 1996
Benzi Kluger, MD, MS (PI) Total Award: $2,000
“Summer Student Fellowship”
The objectives of this fellowship were to introduce promising undergraduate students to the principles
of clinical cancer research and to give them exposure to clinical care.
University of Colorado Denver (UCD), Cancer Center 1997
Benzi Kluger, MD, MS (PI) Total Award: $2,000
“Summer Student Fellowship”
The objectives of this fellowship were to introduce promising undergraduate students to the principles
of clinical cancer research and to give them exposure to clinical care.
American Academy of Neurology 2006-2008
Benzi Kluger, MD, MS (PI) Total Award: $130,000
“Corporate Roundtable Clinical Research Fellowship”
The objectives of this project were to develop and validate novel objective instruments to measure
and understand the physiology of fatigue in neurological diseases.
Role: Principal Investigator
National Institute of Neurological Disorders and Stroke (NINDS) 2006-2013
Irene Litvan, MD (PI) Total Award: $2,747,911
“Genetic and Environmental Risk Factors for Progressive Supranuclear Palsy”
This is a multisite clinical study to identify genetic and environmental risk factors for Progressive
Supranuclear Palsy (PSP).
Role: Site-PI
National Institute of Health (NIH) 2007-2012
Benzi Kluger, MD, MS (PI) Total Award: $32,000
“The NIH Loan Repayment Program (LRP)”
The LRP is designed to assist promising junior investigators dedicated to pursuing a career in clinical
research. Research activities supporting this LRP were focused on developing better measures of
fatigue for Parkinson disease.
Role: Principal Investigator
Neurologix, Inc. 2008-2010
Michael Kaplitt, MD (PI) Total Award: $526,600
“Phase 2 Safety and Efficacy Study Evaluating Glutamic Acid Decarboxylase Gene Transfer to the
Subthalamic Nuclei in Subjects with Advanced Parkinson Disease”
This was a Phase 2 double-blind placebo controlled trial of Glutamic Acid Decarboxylase Gene
Transfer to the Subthalamic Nucleus as a symptomatic therapy for Parkinson disease.
Role: Blind Rater
University of Colorado Denver (UCD) 2009
Benzi Kluger, MD, MS (PI) Total Award: $73,000
“Dean’s Academic Enrichment Fund of the School of Medicine for Strategic Infrastructure Research
Initiative”
This grant supported the development of an interdisciplinary Transcranial Magnetic Stimulation
(TMS) laboratory at the University of Colorado including purchase of a stereotactic TMS guidance
system.
Role: Principal Investigator
Michael J. Fox Foundation (MJFF) 2009-2010
Curt Freed, MD (PI) Total Award: $75,000
“Phenylbutyrate to Prevent Progression of Parkinson’s Disease”
This was a Phase 1 safety study of phenybutyrate as a potential neuroprotective agent in Parkinson
disease.
Role: Co-I
TEVA Pharmaceuticals, LLC 2010-2013
Hubert Fernandez, MD (PI) Total Award: $121,125
“Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson Disease”
This is a double-blind placebo controlled clinical trial of rasagiline for the symptomatic treatment of
fatigue in Parkinson disease.
Role: Co-PI
Michael J. Fox Foundation (MJFF) 2010-2013
Benzi Kluger, MD, MS (PI) Total Award: $477,210
“Acupuncture as a Symptomatic Treatment for Fatigue in Parkinson Disease”
This is a double-blinded placebo controlled clinical trial of acupuncture for the symptomatic
treatment of fatigue in Parkinson disease.
Role: Principal Investigator
Department of Defense (DOD) 2010-2014 (No Cost Extension)
Benzi Kluger, MD, MS (PI) Total Award: $497,250
“Study of Neurophysiology of the Central Fatigue”
The objective of this proposal is to utilize magnetoencephalography (MEG) and transcranical
magnetic stimulation (TMS) to improve our understanding of the central neurophysiological
mechanisms of cognitive performance fatigability in healthy adults.
Role: Principal Investigator
Colorado Clinical and Translational Sciences Institute (CCTSI) 2010-2013
Benzi Kluger, MD, MS (PI) Total Award: $511,840
“(K12) A Novel Approach to Cognitive Dysfunction in Parkinson Disease”
The primary aims of this proposal are to 1) Determine whether magnetoencephalography (MEG)
measures of cortical connectivity are associated with cognitive dysfunction in Parkinson disease and
2) Determine whether MEG measures and/or cognitive performance in Parkinson disease is
modifiable with bifrontal transcranical magnetic stimulation (TMS).
Role: Principal Investigator
NIH / National Institute of Neurological Disorders and Stroke (NINDS) 2011-2015
Margaret Schenckman, PhD (PI) Total Award: $2,993,265
“Exploratory Study of Different does of Endurance Exercise in People with Parkinson Disease
(SPARX)”
This is a multisite clinical trial to determine what is the optimal frequency and intensity of exercise to
modify motor symptoms for patients with early Parkinson disease. The results of this trial will be
used to plan a larger and longer neuroprotection trial of exercise.
Role: CO-I
National Institutes of Health (NIH) / Eunice Kennedy Shriver National Institute of Child Health and
Human Development 2011-2015
Jennifer Stevens-Lapsley, PT, PhD (PI) Total Award: $2,173,119
“Progressive Rehabilitation for Total Knee Arthroscopy”
This is a clinical trial of early and intensive resistance training for patients following total knee
arthroscopy. Transcranial magnetic stimulation and other physiological measures will be used to
better understand the mechanisms of recovery and to identify patients at high risk for suboptimal
outcomes.
Role: CO-I
Colorado Clinical Translational Sciences Institute/Center for Neuroscience 2013-2014
Benzi Kluger, MD, MS (PI) Total Award: $30,000
“Cortical Physiology as a Parkinson’s Disease Biomarker”
This is a pilot study on the potential value of magnetoencephalography as a diagnostic and state-
defining biomarker for Parkinson’s disease.
Role: Principal Investigator
University of Colorado Hospital Clinical Effectiveness and Patient Safety Program 2013-2014
Benzi Kluger, MD, MS (PI) Total Award: $22,389
“Improving Quality of Care, Outcomes and Cost in Neurologic Disease through an Interdisciplinary
Outpatient Palliative Care Clinic”
This is a quality improvement project to optimize the Palliative Care Clinic for Neurology and to
develop a database and other procedures for other outpatient palliative care clinics.
Role: Principal Investigator
Veterans Affairs Medical Center (VAMC)/ Colorado Research to Improve Care Coordination
(CRICC) 2013-2014
Benzi Kluger, MD, MS (PI) Total Award: $30,000
“Defining Palliative Care Needs in Parkinson’s Disease”
The goals of this study are to determine predictors of palliative care needs in patients with
Parkinson’s disease and to see how these needs relate to quality of life.
Role: Principal Investigator
National Institutes of Health (NIH)/ National Institutes of Aging (NIA)/ University of Colorado
Program in Palliative Care Research (K07) 2013-2014
Benzi Kluger, MD, MS (PI) Total Award: $30,000
“Creating a Palliative Care Model for People Living with Parkinson’s disease and their Family
Caregivers: A Patient Centered Approach”
This is a qualitative study to better understand the palliative care needs of people with Parkinson’s
disease and their family caregivers.
Role: Principal Investigator
National Institutes of Health (NIH)/ National Institutes of Neurological Disorders and Stroke
(NINDS) K02NS080885 2013-2018
Benzi Kluger, MD, MS (PI) Total Award: $983,806
“Intrinsic Cortical Networks and Cognitive Dysfunction in Parkinson’s Disease”
This is an Independent Scientist award (K02) to investigate the neurophysiology of cognitive
dysfunction in Parkinson’s disease using magnetoencephalography and to perform a clinical trial of
transcranial magnetic stimulation for cognitive dysfunction in this population.
Role: Principal Investigator
Colorado Clinical Translational Sciences Institute/Center for Neuroscience 2013-2014
Benzi Kluger, MD, MS (PI) Total Award: $60,000
“Rhythmic Enhancement of Motor Performance: Cortical Mechanisms in Healthy Older
Adults and Parkinson's Disease”
This is a pilot using magnetoencephalography to improve our understanding of the mechanisms of
rhythmic enhancement of motor function in Parkinson’s disease.
Role: Principal Investigator
National Institutes of Health (NIH)/National Institutes of Aging (NIA) R21AG044862 2014-2017
Benzi Kluger, MD, MS/M. Ding (Co-PI) Total Award: $412,500
“Measuring Cognitive Fatigability in Older Adults”
This is an Exploratory/Developmental Award (R21) to develop and validate objective behavioral and
electrophysiological measures of cognitive fatigability in older adults.
Role: Co-PI
Parkinson’s Disease Foundation Summer Student Fellowship 2015
Isabelle Boersma (PI) Total Award: $4,000
"Palliative Care in Parkinson's disease: A Mixed Methods Analysis Project”
This is a mentored summer fellowship which will examine the palliative care needs of Parkinson’s
disease patients and their caregivers using qualitative methods.
Role: Primary Mentor
Michael J. Fox Foundation Improved Biomarker and Clinical Outcome Measures Grant 2015-2017
Samantha Holden (PI) Total Award: $165,975
“Validation of a performance-based assessment of functional ability related to cognition in
Parkinson's disease”
The goal of this award is to validate an objective functional battery using cognitive tasks as an
outcome measure and diagnostic tool for Parkinson’s disease dementia.
Role: Primary Mentor
Patient Centered Outcome Research Institute (PCORI): Improving Healthcare Systems 2015-2018
Benzi Kluger, MD, MS (PI)
IHS-1408-20134 Total Award: $1,965,022
“Does Outpatient Palliative Care Improve Patient-Centered Outcomes in Parkinson's Disease?”
This proposal supports a 3 center randomized controlled trial to evaluate the effectiveness of
outpatient team-based palliative care versus usual care for Parkinson’s disease.
Role: Principal Investigator
Parkinson Disease Foundation Conference Award 2015
Benzi Kluger, MD, MS (PI) Total Award: $20,000
“Palliative Care in Parkinson's Disease”
This award will provide funding to conduct the first international working group meeting on clinical
practice and research in Parkinson’s disease using palliative care models.
Role: Principal Investigator
Vaccinex, Inc. 2015-2018
Lauren Seeberger, MD (PI) Total Award: 357,000
“Signal HD”
A Phase 2, multi-center, randomized, double-blind, placebo controlled study in subjects with late
prodromal and early manifest Huntington disease (HD) to assess the safety, tolerability,
pharmacokinetics, and efficacy of VX15/2503
Role: Co-Investigator
ProjectSpark Spark Grant 2016
Taylor Finseth, MD (PI) Total Award: $7,200
“Home-based Neurologic music therapy for management of behavioral symptoms of dementia”
This award will provide funding to conduct a feasibility trial for empowering caregivers of
community living persons with dementia to improve behavioral management and avoid nursing home
placement.
Role: Mentor
National Institutes of Neurologic Disease and Stroke (NINDS) 2016-2018
Benzi Kluger, MD, MS (PI) Total Award: $419,977
R21NS093266
“Characterizing Intrinsic Functional Cortical Networks in Parkinson Disease Dementia”
This is an Exploratory/Developmental Award (R21) to better understand the neurophysiological basis
of Parkinson Disease Dementia using magnetoencephalography and to develop diagnostic and
phenotypic biomarkers.
Role: Co-PI
Parkinson Disease Foundation Conference Award 2016
Keiran Tuck, MD (PI) Total Award: $18,375
“Palliative Care in Parkinson's Disease”
This award will provide funding to conduct the second international working group meeting on
clinical practice and research in Parkinson’s disease using palliative care models.
Role: Co-PI
American Academy of Hospice & Palliative Medicine Mentoring Scholarship 2016-2017
Joel Phillips, MD (PI) Total Award: $1,500
This is a mentored yearlong fellowship which will assist the applicant in initiating an outpatient
neurology palliative care clinic and complete a clinical research project on the advance care
communication preferences of patients with amyotrophic lateral sclerosis (ALS).
Role: Primary Mentor
Davis Phinney Foundation Research Grant 2016-2018
Margaret Schenkman, PhD (PI) Total Award: $42,000
“A Novel Approach to Fatigue in Parkinson’s Disease”
The primary aim of this grant is to determine whether vestibular, ocular or visual dysfunction
contribute to fatigue symptoms in Parkinson’s disease and whether vestibular therapy may improve
symptoms of fatigue in this population.
Role: Co-Investigator
National Institute of Nursing Research (NINR) 2016-2021
Benzi Kluger, MD, MS (PI) Total Award: $2,242,672
R01NR016037
“More than a movement disorder: Applying palliative care to Parkinson’s disease”
This is research project grant (R01) conducting a pragmatic stepped-wedge comparative effectiveness
study of usual care versus usual care augmented by palliative care training and telemedicine support
as a community-based intervention to improve patient and caregiver centered outcomes in
Parkinson’s disease.
Role: Principal Investigator
National Institutes of Health (NIH)/ National Institute on Drug Abuse (NIDA) 3/1/2016 – 2/28/2018
Michael Regner, MD (PI) Direct Costs: $133,394
F32 DA041011
“Novel insular neuromodulation method to alter brain connectivity and reduce cigarette craving in
smokers”
This postdoctoral research fellowship supported Dr. Regner’s time and effort to characterize the role
of the insula in maintaining craving behaviors in current smokers. We conducted a single-blinded,
placebo-controlled, parallel-group single-site randomized clinical trial in adult smokers to determine
the role of the insula in cigarette craving as well as to investigate the use of inhibitory insular
transcranial magnetic stimulation in mitigating craving, altering brain connectivity, and altering brain
activity.
Role: Co-mentor
Colorado Clinical & Translational Sciences Institute (CCTSI) 3/1/2016 – 9/30/2017
Michael Regner, MD (PI) Direct Costs: $30,000
M-15-81
“Novel insular neuromodulation method to alter brain connectivity and reduce cigarette craving in
smokers”
This proposal requested operational funds from a local NIH center, the Colorado Clinical &
Translational Sciences Institute (CCTSI), to conduct Dr. Regner’s Ph.D. dissertation. We conducted
a single-blinded, placebo-controlled, parallel-group single-site randomized clinical trial in adult
smokers to determine the role of the insula in cigarette craving as well as to investigate the use of
inhibitory insular transcranial magnetic stimulation in mitigating craving, altering brain connectivity,
and altering brain activity.
Role: Co-mentor
Radiologic Society of North America (RSNA) 7/1/2016 – 6/30/2018
Michael Regner, MD (PI) Direct Costs: $30,000
RR1620
“Insular inhibitory neuromodulation to reduce cigarette craving and alter brain fMRI connectivity and
activity patterns in smokers”
This resident research award requested operational funds to conduct Dr. Regner’s Ph.D. dissertation.
We conducted a single-blinded, placebo-controlled, parallel-group single-site randomized clinical
trial in adult smokers to determine the role of the insula in cigarette craving as well as to investigate
the use of inhibitory insular transcranial magnetic stimulation in mitigating craving, altering brain
connectivity, and altering brain activity.
Role: Co-mentor
Palliative Care Research Center Investigator Development Pilot Award Program 2017-2018
Hillary Lum, MD (PI) Total Award: $20,232
“Understanding advance care planning in patients and care partners living with Parkinson’s disease”
This pilot qualitative study will explore advance care planning experiences, potential interventions to
improve advance care planning, and the impact of potential future decisional incapacity among
patients and care partners affected by Parkinson’s disease.
Role: Mentor
Data Science to Patient Value, University of Colorado School of Medicine 2017-2018
R. Brett McQueen, PhD (PI) Total Award: $75,000
“Methods for Assessing Sustainability of Health Care Delivery Innovations: Application to Palliative
Care for Neurologic Disorders”
In this pilot project, we will address methodological challenges of health care costing by applying
time-driven activity-based costing (TDABC), a costing approach that engages clinical and financial
teams to accurately estimate resources and costs involved in treating patients over their entire care
cycle. We will apply TDABC to the cycle of care for patients with Parkinson’s disease at the
neurology PC clinic. Our goal of this pilot project is to estimate the incremental costs of the
University of Colorado neurology PC clinic as compared to a clinic without PC services to quantify
opportunities to improve returns on investing in neurology PC. In conjunction with a Patient Centered
Outcomes Research Institute (PCORI) grant (Kluger PI), this pilot project will directly advance the
mission of D2V within the Patient & System Value Core by determining the value and sustainability
of expanding innovative care models such as neurology PC to other life-limiting conditions and
ambulatory settings.
Role: Mentor
Neurological Sciences Academic Development Award 7/1/2017-6/30/2020
Joshua Bear, MD, MA (PI) Total Award: $102,000
“Functional Connectivity and Electrical Status Epilepticus in Sleep”
This pilot computational study will use advanced analytical techniques in fMRI and MEG to examine
the effect of ESES on the large-scale intrinsic networks of the brain in children with ESES.
Role: Mentor
Colorado Clinical & Translational Sciences Institute (CCTSI) 3/1/2017-2/28/2018
Brice McConnell, MD, PhD (PI) Direct Costs $30,000
“Application of Transcranial Alternating Current Stimulation for Modulation of Sleep and Cognitive
Performance in Patients with Mild Cognitive Impairment”
The goal of this award is to develop technological methods via a series of pilot-scale randomized,
controlled clinical trials testing an at-home, automated system to deliver transcranial alternating
current stimulation (tACS) during slow wave sleep for treatment of sleep and cognitive impairment
among patients with amnestic mild cognitive impairment (aMCI).
Role: Mentor
Michael J. Fox Foundation 10/1/2017-9/30/2019
Samantha Holden, MD (PI) Total Award $164,988
“Can baseline functional abilities predict future cognitive decline in Parkinson's disease?”
The goal of this award is to determine the predictive ability of a performance-based cognitive
functional assessment for cognitive decline in Parkinson’s disease and to delineate risk factors of
future cognitive decline in PD.
Role: Mentor
NIH/NIA 09/15/2016 – 06/30/2021
Benzi Kluger, MD, MS (PI) Total Award $406,379
3R01NR016037
“More than a Cognitive Disorder: Applying Palliative Care to Alzheimer’s Disease”
This proposal is a one year supplement to expand the activities of an ongoing pragmatic clinical trial
of community-based palliative care for Parkinson’s disease to AD with the specific objectives of: a)
Determining how palliative care issues contribute to QOL in AD through quantitative surveys and
qualitative interviews; b) Assessing the feasibility of our current model of community-based
palliative care for AD patients and families; and c) Optimizing our intervention through the results of
objectives ‘a’ and ‘b’ to design a comparative effectiveness trial specifically focused on AD.
Role: PI
Bibliography: Peer-reviewed Articles:
1. Krebs NF, Westcott JE, Arnold TD, Kluger BM, Accurso FJ, Miller LV, Hambidge KM.
Abnormalities in zinc homeostasis in young infants with cystic fibrosis. Pediatric Research. 2000;
48(2):256-261.
2. Drago V, Foster PS, Trifiletti D, Fitzgerald DB, Kluger BM, Crucian GP, Heilman KM. What’s
inside the art? The influence of frontotemporal dementia in art production. Neurology. 2006;
67(7):1285-1287.
3. Kluger BM, Heilman KM. Dysfunctional facial emotional expression and comprehension in a patient
with corticobasal degeneration. Neurocase. 2007; 13(3):165-168.
4. Kluger BM, Heilman KM. Disruption of reciprocal coordination by a medial frontal stroke sparing
the corpus callosum. Cognitive and Behavioral Neurology. 2007; 20(4):230-231.
5. Kluger BM, Triggs WJ. Uses of transcranial magnetic stimulation to influence behavior. Current
Neurology and Neuroscience Reports. 2007; 6(7):491-497.
6. Kluger BM, Hughes RL, Anderson CA, Hassell KM. Non-traumatic carotid dissection and stroke
associated with anti-phospholipid antibody syndrome. Neurology India. 2008; 56(1):77-78.
7. Kluger BM, Meador KJ, Garvan CW, Loring DW, Juras DM, Townsend DT, Heilman KM. A test of
the mechanisms of sensory extinction to simultaneous stimulation. Neurology. 2008; 70(18):1644-
1645.
8. Heilman KM, Coenen A, Kluger BM. Asymmetric Apraxic Agraphia: An early sign of corticobasal
degeneration. Cognitive and Behavioral Neurology. 2008; 21(1):14-17.
9. Kluger BM, Meador KJ. Teratogenicity of antiepileptic medications. Seminars in Neurology. 2008;
28(3):328-335.
10. Drago V, Foster PS, Skidmore FM, Kluger B, Antoniello D, Heilman KM. Attentional grasp in
Parkinson disease. Cognitive and Behavioral Neurology. 2008; 21(3):138-142.
11. Classen S, McCarthy DP, Schectman O, Awadzi KD, Lanford DN, Okun MS, Rodriguez RL,
Romrell J, Bridges S, Kluger B, Fernandez HH. Useful field of view as a reliable screening measure
of driving performance in people with Parkinson’s disease: results of a pilot study. Traffic Injury
Prevention. 2009;10(6):593-598.
12. Kluger BM, Saunders LV, Hou W, Garvan CW, Kirli S, Efros DB, Chau QN, Crucian GP, Finney
GR, Meador KJ, Heilman KM. A brief computerized self-screen for dementia. Journal of Clinical
and Experimental Neuropsychology. 2009; 31(2):234-244.
13. Kluger BM, Klepitskaya O, Okun MS. Surgical treatment of movement disorders. Neurologic
Clinics; 2009; 27(3):633-677.
14. Soeder A, Kluger BM, Okun MS, Garvan CW, Soeder T, Jacobson CE, Rodriguez RL, Turner R,
Fernandez HH. Mood and energy determinants of quality of life in dystonia. Journal of Neurology.
2009; 256(6):996-1001.
15. Kluger BM, Garvan CW, Loring DW, Juras DM, Townsend DT, Heilman KM, Meador KJ. Loss of
somatosensory evoked potentials and the timing of perception. Cognitive and Behavioral Neurology.
2009; 22(3):173-179.
16. Antoniello D, Kluger B, Sahlein DH, Heilman KM. Phantom limb after stroke: an underreported
phenomenon. Cortex. 2010; 46(9):1114-1122.
17. Triggs WJ, Ricciuti N, Ward HE, Cheng J, Bowers D, Goodman WK, Kluger BM, Nadeau SE. Right
and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-
controlled trial. Psychiatry Research. 2010; 178(3):467-474.
18. Kluger BM, Foote KD, Jacobson CE, Okun MS. Lessons learned from a large single center cohort of
patients referred for DBS management. Parkinsonism and Related Disorders. 2011; 17(4):236-239.
19. Kuyper DJ, Parra V, Aerts S, Okun MS, Kluger BM. Nonmotor manifestations of dystonia: a
systematic review. Movement Disorders. 2011; 26(7):1206-1217.
20. Stevens-Lapsley J, Kluger B, Schenkman M. Quadriceps muscle weakness, activation deficits and
fatigue with Parkinson’s disease. Neurorehabilitation and Neural Repair. 2012; 26(5):533-541.
21. Kluger BM, Palmer C, Shattuck J, Triggs W. Motor evoked potential depression following repetitive
central motor initiation. Experimental Brain Research. 2012; 216(4):585-590.
22. Kluger BM, Parra V, Jacobson C, Garvan C, Rodriguez R, Fernandez H, Fogel A, Skoblar D,
Bowers D, Okun M. The prevalence of fatigue following deep brain stimulation surgery in
Parkinson’s disease and association with quality of life. Parkinson’s Disease. 2012; 2012:769506.
23. McConnell B, Masny P, Kluger BM. Opisthotonic posturing in an adult with a cerebellopontine
angle mass. Movement Disorders. 2012; 27(9):1093.
24. Stevens-Lapsley JE, Thomas AC, Hedgecock JB, Kluger BM. Corticospinal and intracortical
excitability of the quadriceps in active older and younger healthy adults. Archives of Gerontology and
Geriatrics. 2013; 56(1):279-284.
25. Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: proposal for a
unified taxonomy. Neurology. 2013; 80(4):409-416.
26. Haug A, Boyer P, Kluger B. Diffuse lewy body disease presenting as corticobasal syndrome and
progressive supranuclear palsy syndrome. Movement Disorders. 2013; 28(8):1153-1155.
27. VanLoh M, Chen R, Kluger B. Safety of transcranial magnetic stimulation in Parkinson's disease: a
review of the literature. Parkinsonism and Related Disorders. 2013; 19(6):573-585.
28. Shipley SM, Frederick MC, Filley CM, Kluger BM. Potential for misdiagnosis in community-
acquired PET scans for dementia. Neurology: Clinical Practice. 2013; 3(4):305-312.
29. Combs S, Kluger BM, Kutner JS. Research priorities in geriatric palliative care: nonpain symptoms.
Journal of Palliative Medicine. 2013; 16(9):1001-1007.
30. Dilli CR, Childs R, Berk J, Christian MK, Nguyen N, Brown RP, Kluger BM. Does prior
acupuncture exposure affect perception of blinded real or sham acupuncture? Acupuncture in
Medicine. 2014; 32(2):155-159.
31. Marker RJ, Stephenson JL, Kluger BM, Curran-Everett D, Maluf K. Modulation of intracortical
inhibition in response to acute psychosocial stress is impaired among individuals with chronic neck
pain. Journal of Psychosomatic Research. 2014; 76(3):249-256.
32. Wang C, Ding M, Kluger BM. Change in intraindividual variability over time as a key metric for
defining performance-based cognitive fatigability. Brain and Cognition. 2014; 85:251-258.
33. McConell B, Applegate M, Keniston A, Kluger B, Maa E. Use of complementary and alternative
medicine in an urban county hospital epilepsy clinic. Epilepsy & Behavior. 2014; 34:73-76.
34. Kluger BM, Brown RP, Aerts S, Schenkman M. Determinants of objectively measured physical
functional performance in early to mid-stage Parkinson disease. PM&R: the journal of injury,
function and rehabilitation. 2014; 6(11):992-998.
35. Hall DA, Bennett DA, Filley CM, Shah RC, Kluger B, Ouyang B, Berry-Kravis E. Fragile X gene
expansions are not associated with dementia. Neurobiology of Aging. 2014; 35(11):2637-2638.
36. Boersma I, Miyasaki J, Kutner J, Kluger BM. Palliative care and neurology: time for a paradigm
shift. Neurology. 2014; 83(6):561-567.
37. Kittelson AJ, Thomas AC, Kluger BM, Stevens-Lapsley JE. Corticospinal and intracortical
excitability of the quadriceps in patients with knee osteoarthritis. Experimental Brain Research. 2014;
232(12):3991-3999.
38. Kluger B, Triolo P, Jones W, Jankovic J. The therapeutic potential of cannabinoids for movement
disorders. Movement Disorders. 2015; 30(3):313-327.
39. Finseth TA, Hedeman JL, Brown RP, Johnson KI, Binder MS, Kluger BM. Self-reported efficacy of
cannabis and other complementary medicine modalities by Parkinson’s disease patients in Colorado.
Evidence Based Complementary and Alternative Medicine. 2015; 2015:874849.
40. Holden S, Jones WE, Baker KA, Boersma IM, Kluger BM. Outcome measures for Parkinson’s
disease dementia: a systematic review. Movement Disorders: Clinical Practice. 2016; 3(1):9-18.
41. Lim TT, Kluger BM, Rodriguez RL, Malaty IM, Palacio R, Ojo O, Patel S, Gujrati Y, Nutter B,
Swartz C, Hennessy C, Fernandez HH. Rasagiline for the symptomatic treatment of fatigue in
Parkinson’s disease. Movement Disorders. 2015; 30(13):1825-1830.
42. Wang C, Ding M, Kluger BM. Functional roles of neural preparatory processes in a cued Stroop task
revealed by linking electrophysiology with behavioral performance. PLOS One. 2015;
10(7):e0134686.
43. Wagle Shukla A, Brown R, Heese K, Jones J, Rodriguez RL, Malaty IM, Okun MS, Kluger BM.
High rates of fatigue and sleep disturbances in dystonia. International Journal of Neuroscience. 2016;
126(10):928-935.
44. Friedman J, Beck J, Chou K, Clark G, Fagundes C, Goetz C, Herlofson K, Kluger B, Krupp L, Lang
A, Lou JS, Marsh L, Newbould A, Weintraub D. Fatigue in Parkinson’s disease: report from a
multidisciplinary symposium. npj Parkinson’s Disease. 2016; 2:15025.
45. Kluger BM, Herlofson K, Chou KL, Lou JS, Goetz CG, Lang AE, Weintraub D, Friedman J.
Parkinson’s disease-related fatigue: a case definition and recommendations for clinical research.
Movement Disorders. 2016; 31(5):625-631.
46. Litvan I, Lees PS, Cunningham CR, Rai SN, Cambon AC, Standaert DG, Marras C, Juncos J, Riley
D, Reich S, Hall D, Kluger B, Bordelon Y, Shprecher DR, for ENGENE-PSP. Environmental and
occupational risk factors for progressive supranuclear palsy: case-control study. Movement Disorders.
2016; 31(5):644-652.
47. Brody B, Litvan I, Warner S, Hall D, Kluger B, Cunningham C. Relationship between uric acid
levels and progressive supranuclear palsy. Movement Disorders. 2016; 31(5):663-667.
48. Borah S, McConnell, Hughes R, Kluger B. Potential relationship of self-injurious behavior to right
temporo-parietal lesions. Neurocase. 2016; 22(3):269-72.
49. Kluger BM, Rakowski D, Christian M, Cedar D, Wong B, Crawford J, Uveges K, Berk J, Abaca A,
Corbin L, Garvan C. Randomized controlled trial of acupuncture for fatigue in Parkinson’s disease.
Movement Disorders. 2016; 31(7):1027-1032.
50. Boersma IM, Jones J, Carter J, Bekelman D, Miyasaki J, Kutner JS, Kluger B. Parkinson’s disease
patients’ perspectives on palliative care needs: what are they telling us? Neurology Clinical Practice.
2016; 6(3):209-219.
51. Wang C, Trongnetrpunya A, Samuel IB, Ding M, Kluger BM. Compensatory neural activity in
response to cognitive fatigue. Journal of Neuroscience. 2016; 36(14):3919-3924.
52. Childs R, Dilli CR, Christian MK, Wong B, Dong D, Corbin L, Kluger BM. Acupuncture for the
symptomatic treatment of fatigue in Parkinson’s disease: trial design and implementation. Medical
Acupuncture. 2016; 28(4):194-205.
53. Buard I, Martin CS, Kluger BM. Cortical physiology as a therapeutic target in Parkinson’s disease
related dementia and cognitive dysfunction: study protocol for a randomized controlled trial. Clinical
Trials in Degenerative Diseases. 2016; 1(3):91-98.
54. Liu Y, Kline D, Aerts S, Youngwerth JM, Kutner JS, Sillau S, Kluger BM. Inpatient palliative care
for neurologic disorders: lessons from a large retrospective series. Journal of Palliative Medicine.
2017; 20(1):59-64.
55. Allen CH, Kluger BM, Buard I. Safety of transcranial magnetic stimulation in children: A systematic
review of the literature. Pediatric Neurology. 2017; 68:3-17.
56. Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B,
Shprecher D, Marras C, Jankovic J, ENGENE PSP study group. Understanding falls in progressive
supranuclear palsy. Parkinsonism and Related Disorders 2017; 35:75-81.
57. Kluger BM, Fox S, Timmons S, Katz M, Galifianakis NB, Subramanian I, Carter JH, Johnson MJ,
Richfield EW, Bekelman D, Kutner JS. Palliative Care and Parkinson's disease: Meeting summary
and recommendations for clinical research. Parkinsonism & Related Disorders. 2017; 37:19-26.
58. Herlofson, K, Kluger BM. Fatigue in Parkinson’s disease. Journal of the Neurological Sciences.
2017; 374:38-41.
59. Kluger BM, Pedersen KF, Tysnes OB, Ongre SO, Øygarden B, Herlofson K. Is fatigue associated
with cognitive dysfunction in early Parkinson's disease? Parkinsonism & related disorders. 2017; 37:87-91.
60. Christiansen C, Moore C, Schenkman M, Kluger B, Kohrt W, Delitto A, Berman B, Hall D, Josbeno
D, Poon C, Robichaud J, Wellington T, Jain S, Comella C, Corcos D, Melanson E. Factors
Associated With Ambulatory Activity in De Novo Parkinson Disease. J Neurol Phys Ther. 2017;
41(2):93-100.
61. Hall K, Sumrall M, Thelen G, Kluger, BM. Palliative care for Parkinson’s disease: suggestions from
a council of patient and carepartners. npj Parkinson's Disease. 2017; 3(1):16
62. Kluger BM, Garimella S, Garvan C. Minimal Clinically Important Difference of the Modified
Fatigue Impact Scale in Parkinson’s Disease. Parkinsonism and Related Disorders. 2017; 43:101-4.
63. Boersma I, Jones J, Coughlan C, Carter J, Bekelman D, Miyasaki J, Kutner J, Kluger B. Palliative
Care and Parkinson's Disease: Caregiver Perspectives. Journal of Palliative Medicine. 2017; 20:930-
938.
64. Gerstenecker A, Roberson ED, Schellenberg GD, Standaert DG, Shprecher DR, Kluger BM, Litvan
I. Genetic Influences on Cognition in Progressive Supranuclear Palsy. Movement Disorders. 2017;
1764-71.
65. Buard I, Sciacca DM, Martin CS, Rogers S, Sillau SH, Greher MR, Chen R, Kluger BM. Repetitive
Transcranial Magnetic Stimulation Does Not Improve Mild Cognitive Impairment in Parkinson’s
Disease. Movement Disorders. 2018; 33(3):489-91.
66. Kluger BM, Persenaire MJ, Holden SK, Palmer LT, Redwine H, Berk J, Anderson CA, Filley CM,
Kutner J, Miyasaki J, Carter, J. Implementation Issues Relevant to Outpatient Neurology Palliative
Care. Annals of Palliative Medicine. 2017.
67. Marras C, Lees PS, Cunningham CR, Hou J, Proudfoot J, Standaert DG, Juncos J, Riley D, Reich SG,
Hall D, Kluger B. Anti-inflammatory drug use and progressive supranuclear palsy. Parkinsonism &
Related Disorders. 2018;48:89-92.
68. Schenkman M, Moore CG, Kohrt WM, Hall DA, Delitto A, Comella CL, Josbeno DA, Christiansen
CL, Berman BD, Kluger BM, Melanson EL. Effect of High-Intensity Treadmill Exercise on Motor
Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial.
JAMA neurology. 2018; 75(2):219-26. 69. Tartavoulle T, Karpinski A, Aubin A, Kluger B, Distler O, Saketkoo L. Multi-dimensional Fatigue in
Pulmonary Hypertension: Prevalence, Severity and Predictors. ERJ Open Research. 2018; Jan
1;4(1):00079-2017. 70. Hall D, Ramos A, Benatar M, Gelfand M, Videnovic A, Cahill C, Kluger B, Goldman M. The State
of Clinical Research in Neurology. Neurology. 2018; 10-212.
71. Jones W, Silkworth W, Dusto N, Pelak VS, Berliner J, Buard I, Kluger B. Central Visual Oscillopsia:
Case Report and Review of the Literature. Cognitive and Behavioral Neurology. 2018; Jun
1;31(2):86-95.
72. Tartavoulle TM, Karpinski AC, Aubin A, Kluger BM, Distler O, Saketkoo LA. Multidimensional
fatigue in pulmonary hypertension: prevalence, severity and predictors. ERJ Open Research. 2018 Jan
1;4(1):00079-2017.
73. Park HK, Ilango S, Charriez CM, Checkoway H, Riley D, Standaert DG, Bordelon Y, Shprecher DR,
Reich SG, Hall D, Kluger B, Marras C, Jankovic J, Dubinsky R, Litvan I. Lifetime exposure to
estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. Movement
Disorders. 2018 Mar;33(3):468-472.
74. Berliner JM, Kluger BM, Corcos DM, Pelak VS, Gisbert R, McRae C, Atkinson CC, Schenkman M.
Patient perceptions of visual, vestibular, and oculomotor deficits in people with Parkinson’s disease.
Physiotherapy theory and practice. 2018 Jul 5:1-8. 75. Creutzfeldt CJ, Kluger B, Kelly AG, Lemmon M, Hwang DY, Galifianakis NB, Carver A, Katz M,
Curtis JR, Holloway RG. Neuropalliative care: Priorities to move the field forward. Neurology. 2018
Jun 27:10-212. 76. Buard I, Berliner JM, Kluger BM. Low Frequency repetitive Transcranial Magnetic Stimulation:
Potential role in treatment of patients with hemispheric cerebellar strokes. Brain Stimulation. 2018
May - Jun;11(3):653-655. 77. Sebring K, Shattuck J, Berk J, Boersma I, Sillau S, Kluger BM. Assessing the validity of proxy
caregiver reporting for potential palliative care outcome measures in Parkinson’s disease. Palliative
medicine. 2018 Jul 1:0269216318785830. 78. Braunlich K, Seger C. Jentick KG, Buard I, Kluger BM, Thaut MH. Rhythmic auditory cues shape
neural network recruitment in Parkinson¹s disease during repetitive motor behavior. European
Journal of Neuroscience. 2018 Oct 29. 79. Holden SK, Medina LD, Hoyt B, Sillau SH, Berman BD, Goldman JG, Weintraub D, Kluger BM.
Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.
Movement Disorders. 2018 Oct 10. [Epub ahead of print] 80. Katz M, Goto Y, Kluger BM, Galifianakis NB, Miyasaki JM, Kutner JS, Jones CA, Pantilat SZ. Top
Ten Tips Palliative Care Clinicians Should Know About Parkinson's Disease and Related Disorders.
Journal of Palliative Medicine. 2018 Oct;21(10):1507-1517. 81. Buard I, Dewispelaere W, Kluger BM. Neurophysiological Evidence of Altered Cortical Activity and
Connectivity with Neurologic Music Therapy in Parkinson’s Disease. Frontiers in Neuroscience.
2019;13:105. 82. Kluger BM, Zhao Q, Tanner J, Schwab N, Levy S, Burke S, Huang H, Ding M, Price C. Structural
brain correlates of fatigue in older adults with and without Parkinson's disease. NeuroImage: Clinical.
2019. In Press. 83. Kluger BM, Katz, M, Galifianakis N, Pantilat S, Kutner J, Sillau S, Grtiz M, Jones J, Fairclough
D, Sumrall M, Hall K, Miyasaki J. Does Outpatient Palliative Care Improve Patient-Centered
Outcomes in Parkinson’s Disease: Rationale, Design, and Implementation of a Pragmatic
Comparative Effectiveness Trial. Contemporary Clinical Trials. 2019. In Press.
Books:
1. Creutzfeld C, Kluger BM, Holloway RH, (eds.) Neuropalliative Care. New York, NY: Springer
Publishing Company. 2018.
Book Chapters:
1. Kluger BM, Reckess G. (2013). Perception and Recognition. In Arciniegas DB, Anderson CA, Filley
CM, (eds.) Behavioral Neurology and Neuropsychiatry (pps. 144-160). New York, NY: Cambridge
University Press.
2. Kluger BM, Friedman JH (2009). Fatigue in Parkinson’s Disease. In Chaudhuri K, Tolosa E,
Schapira A, Poewe W, (eds.) The Non-motor Symptoms Complex of Parkinson’s Disease. (pp. 135-
146). New York, NY: Oxford University Press.
3. Kluger BM, Fernandez HH (2009). Management of Non-motor Manifestations of Parkinson’s
Disease. In Simuni T and Pahwa R, (eds.) Parkinson’s Disease: A Practical Guide to Diagnosis and
Management. (pp 83-94). New York, NY: Oxford University Press.
4. Kluger BM, Krupp LB (2014). Invisible Symptoms - Fatigue, Depression, and Cognition. In
Samkoff L, Goodman AD, (eds.) Multiple Sclerosis and CNS Inflammatory Disorders. (pp 114-121).
Hoboken, NJ: Wiley-Blackwell.
5. Glover TL, Kluger BM. Palliative Medicine and End of Life. Handbook of Clinical Neurology. In
Press.
6. Kluger BM (2017). Fatigue in Parkinson’s disease. In Chaudhuri KR and Titova N (eds.),
International Review of Neurobiology Non Motor Parkinson's: The Hidden Face, Volume 133: The
Many Hidden Faces (pps. 743-768). Cambridge: MA: Elsevier Inc.
7. Kluger BM (2018). Caring for Patients and Families affected by Advanced Parkinson’s disease. In
Robinson MT (ed.), Case Studies in Neuropalliative Care. Cambridge University Press; 2018 May
31.
8. Kluger BM (2018). Making a Diagnosis with Compassion in Parkinson’s disease. In Robinson MT
(ed.), Case Studies in Neuropalliative Care. Cambridge University Press; 2018 May 31.
Invited Articles, Editorials and Reviews: 1. Ghaffari B, Kluger B. Mechanisms for alternative treatments in Parkinson’s disease: acupuncture, tai
chi and others. Current Neurology and Neuroscience Reports. 2014; 14(6):451.
2. Kluger BM, Miyasaki J. Palliative Care and Neurology: Time for a Paradigm Shift: Author
Response. Neurology. 2014; 84(11):1184.
3. Miyasaki JM, Kluger BM. Palliative care for parkinson’s disease: has the time come? Current
Neurology and Neuroscience Reports. 2015; 15(5):26.
4. Vaughan C, Kluger BM. Palliative Care for Movement Disorders. Current Treatment Options in
Neurology. 2018; 20(1):2.
Scientific Abstracts (Competitive): 1. Kluger BM, Arnold TD, Miller LV, Accurso FJ, Krebs NF. Zinc homeostasis in infants with cystic
fibrosis. J Investig Med. 1997; 46(1):67A.
2. Kluger BM, Rojas DC, Kronenberg E, Filley CM. Volitional Action as Assessed by
Magnetoencephalography. J Neuropsychiatry Clin Neurosci. 2005; 17:274.
3. Kluger BM, Rojas DC, Kronenberg E, Filley CM. Volitional Action as Assessed by
Magnetoencephalography. Clin EEG and Neurosci. 2005; 36(3): 246.
4. Kluger BM, Heilman KM. Dysfunctional facial emotional expression and comprehension in a patient
with corticobasal degeneration. J Int Neuropsychol Soci. 2007; 13 (Suppl 1); 13
5. Kluger BM, Meador KJ, Loring DW, Townsend D, Heilman KM. A test of the mechanisms of
sensory extinction to simultaneous stimulation. Neurology. 2007; 68(Suppl 1):A8
6. Kluger BM, White K, McGregor K, Drago V, Mizuno T, Crosson B, Okun M, Heilman K. An fMRI
study of the crossed response inhibition test in Parkinson’s Disease. Proceedings of the 13th Annual
Cognitive Neuroscience Society Annual Meeting. 2007; 101
7. Rogalski Y, Dieuvil M, Kluger B, Heilman K. Aging and Affect: Emotional Word and Picture
Ratings in Older versus Younger Adults. J J Int Neuropsychol Soci. 2008; 14 (Suppl 1); 164
8. Dieuvil M, Rogalski Y, Kluger B, Beversdorf D, Raymer A, Williamson D, Heilman K. Assessment
of Emotional Semantics in Early Alzheimer's Disease. J Int Neuropsychol Soci. 2008; 14(Suppl 1);
267
9. Kluger BM, Garvan CW, Jacobson C, Bowers D, Fogel A, Skoblar B, Rodriguez R, Fernandez HH,
Okun MS. The Prevalence and Clinical Significance of Fatigue following Deep Brain Stimulator
Surgery in Parkinson’s Disease. Neurology. 2008; 70 (Suppl 1): A177
10. Saunders LV, Chau QN, Kluger BM, Garvan CW, Kirli S, Efros DB, Crucian GP, Finney GR,
Meador KJ, Heilman KM. A brief computerized self-screen for dementia. Neurology. 2008; 70 (Suppl
1): A184-5
11. Malaty IA, Kluger B, Jacobson C, Okun M, Fernandez H. Detecting Depression in Parkinson’s
Disease: How Useful is the Unified Parkinson Disease Rating Scale? Neurology. 2008; 70 (Suppl 1):
A287
12. McCarthy DP, Justiss MD, Lanford D, Kluger B, Okun M, Rodriguez RL, Romrell J, Mann WC,
Rodriguez E, Faucher FF, Wu S, Fernandez H. Useful Field of View Performance among Drivers
with Parkinson’s Disease. Neurology. 2008; 70 (Suppl 1): A51
13. Saunders L, Kluger B, Kirili S, Efros D, Crucian G, Garvan C, Chau A, Finney G, Heilman K.
Validation of a Self-Administered Computerized Screening Test for Cognitive Impairment and
Dementia. Neurology. 2008; 70 (Suppl 1 ): A184
14. Proemsey JB, Kluger B, Rajagovindan R, Ding B, Skidmore R, Okun M, Heilman K. A Study of
Cognitive Fatigue. Neurology. 2009; 72 (Supp. 3):A323
15. Klepitskaya OS, Fowler JJ, Kluger BM, Ojemann SG. Number of microelectrode recording passes
during bilateral staged vs. Unstaged deep-brain stimulation surgery for Parkinson’s disease. Mov
Disord, 2009; 24 (Suppl 1): S485
16. Andersen C, Kluger B, Garvan C, Classen S, Fernandez H, Mennemeier M, McCarthy D. Magnitude
estimation in Parkinson’s disease. Mov Disord, 2009 (Suppl 1):S289-90
17. Proemsey JB, Kluger B, Rajagovindan R, Ding M, Skidmore F, Okun M, Heilman K. A study of
cognitive fatigue in Parkinson’s disease. Mov Disord, 2009 (Suppl 1):S248.
18. Aerts S, Schenkman M, Riolo L, Zheng C, Kumar R, Kluger B. Executive Function and Functional
Mobility in Parkinson's Disease. J Int Neuropsychol Soci. 2010; 16 (Suppl 1): 115
19. Parra V, Garvan C, Jacobson C, Rodriguez R, Fernandez H, Fogel A, Skoblar B, Bowers D, Okun M,
Kluger B. The Prevalence and Clinical Significance of Fatigue following Deep Brain Surgery in
Parkinson’s Disease. J Int Neuropsychol Soci. 2010; 16 (Suppl 1): 51
20. Kluger BM, Wang C, Rajagovindan R, Proemsey J, Ding M. Neuronal Correlates of Executive
Dysfunction in Parkinson’s Disease. Clinical and Translational Science. 2012:5(2):191
21. Heese K, Wagle Shukla A, Okun M S, Kluger B. Fatigue, Sleepiness and Sleep Issues in Patients
with Dystonia. Neurology. 2012 (Suppl 1): 78:PO1.224
22. Kluger BM, Shipley S, Filley C. Accuracy of community-acquired PET scans for the diagnosis of
dementia. Neurology. 2012 (Suppl 1): 78:PD1.010
23. Hall D, Filley C, Shah R, Bennett D, Kluger B, Berry-Kravis. Frequency of Fragile X Gene
Expansions in Alzheimer Disease and Other Cognitive Disorders. Neurology. 2012; 78 (Suppl 1):
P05.074
24. Kluger BM, Wang C, Proemsey J, Ding M. Neuronal Correlates of Executive Dysfunction and
Fatigability in Parkinson Disease. Movement Disorders. 2012: 27(4):e6.
25. McRae C, Rogers S, Grine S, Kluger BM. Differences between actual and perceived treatment
groups in a double-blind placebo trial of acupuncture for fatigue in Parkinson’s disease. World
Parkinson Congress. 2016.
26. Miyasaki J, Katz M, Galifianakis N, Kluger BM. Does outpatient palliative care improve patient
centered outcomes in Parkinson’s disease: study protocol for a multi-center randomized controlled
trial. World Parkinson Congress. 2016.
27. Regner MF, Kluger B, Tregellas T, Mohl B, Yamamoto D, Tanabe J. Inhibiting the Insula in
Smokers: Preliminary Results from a RCT using Transcranial Magnetic Stimulation and fMRI.
American Society of Neuroradiology, 55nd Annual Meeting. Long Beach CA: April 22-28, 2017. 8
minute oral research presentation.
28. Regner MF, Kluger B, Tregellas T, Mohl B, Yamamoto D, Tanabe J. “Inhibiting the Insula in
Smokers: Preliminary Results using Transcranial Magnetic Stimulation and fMRI.” College on the
Problems of Drug Dependence (CPDD). Montreal, QC, Canada: June 17-22, 2017.
Other Media
2014 Interviewed as Alzheimer’s Disease expert following Pat Bowlen revealing his diagnosis
for CBS-4, Fox-31, CW-2 television and KEZW radio.
2014 Interviewed as Parkinson’s Disease expert following Robin William’s suicide and
diagnosis for Fox-31 and ABC-7.
2014 Interviewed as Behavioral Neurology expert for Colorado Public Radio and National
Public Radio (NPR) piece: “For some Alzheimer’s patients musical memories stir while
others fade”.
2015 Interviewed as Parkinson’s Disease expert for “Parkinson’s leads Dr. Gregory Jaramillo
to face his own mortality—and to live well” by Pam Mellskog for the Longmont Times-
Call Newspaper.
2016 Article “Parkinson disease patients’ perspectives on palliative care needs: what are they
trying to tell us?” selected for editorial and podcast interview for Neurology Clinical
Practice.
2016 Does PD affect thinking and memory? Online Webinar. Posted by American Association
of Retired Persons and Parkinson’s Association of the Rockies.
2017 Invited as a palliative care expert for interview with Murphy Huston on AM 1430 KEZW
(aired twice on May 4, 2017) to educate the public on services available at University of
Colorado Supportive and Palliative Care program.
2017 Fatigue in Parkinson’s Disease, blog contributor; If fatigue is so common in patients with
PD, how do we decide if fatigue is affecting patients’ quality of life?
https://www.movementdisorders.org/MDS/Scientific-Issues-Committee-Blog/Fatigue-in-
Parkinsons-Disease.htm
2018 World Parkinson’s Coalition, blog contributor; Palliative Care is about Living as well as
Possible as long as Possible.
https://www.worldpdcongress.org/home/2018/1/5/lrnx5kclrl8bn7tqb0jeh0vnqz3gon
2018 Contributed to 38 Science-Backed Tricks to Sharpen Your Memory, October 5, 2018.
Last Updated: February 22, 2019